Read reports from two fellows who completed their fellowships in FRance in 2019 and 2020.			
		Join Now for Bonus Months! Plus: October Renewal Discount and Special Benefit for Associate Members
																October 1, 2025
									
					
				Join us now and take advantage of bonus months. Active individual members enjoy October discount for renewals and associate members special a benefit! 			
			EAN Associate Members Get Access to EAN Congress 2025 Content for October!
																September 26, 2025
									
								Latest Posts
- 
	
- 
	EAN NewsTop ArticlesRESEARCH PAPER OF THE MONTH: Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophyMay 5, 2020For 2020, we have selected: Shahnawaz M, Mukherjee A, Pritzkow S et al. Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy.
- 
	EAN NewsCOVID-19Top ArticlesUncategorizedFrench Neurologists in the time of Covid-19: multi-disciplinary, challenges and new horizonsMay 2, 2020As any place in Europe and beyond, the French health system is still under pressure and Covid-19 has already and will profoundly change healthcare.
- 
	As soon as the dramatic developments in our European fellow countries Italy, France, and Spain came to our attention, an emergency plan was deployed across the country. Besides coordinating logistics of allocating protection gear and respirators, all hospitals with the respective competence and resources in intensive care medicine have systematically ramped up their capacities.
- 
	Giovanni Di Liberto, MD-PhD Chair, RRFS – Residents and Research Fellows Section of the EAN Dr. Thomas Jenkins, Chair of the EAN e-Communication Committee interviews: Dear Dr. Di Liberto, You recently took over the leadership of the RRFS EAN section.… Continue Reading
- 
	Neurological disorders are mostly chronic, long-term conditions. Those affected may be at increased risk from Covid-19. However, as this strain of the coronavirus is new, the knowledge on how this will affect people with neurological disorders is still limited. Based… Continue Reading
- 
	Other NewsEMA communication: “Human Medicines Highlights” Newsletter – April 2020 issueMay 1, 2020New gene therapy to treat spinal muscular atrophy On March 27, European Medicines Agency (EMA) recommended granting a conditional marketing authorisation in the European Union for the gene therapy Zolgensma (onasemnogene abeparvovec) to treat babies and young children with spinal… Continue Reading
- 
	The European Brain Research Area project – EBRA – was created as a catalyzing platform for brain research stakeholders (researchers, clinicians, patients, governments, funders and public institutions) to streamline and better coordinate brain research across Europe while fostering global initiatives.… Continue Reading
- 
	This document aims to update and clarify some emerging issues in the EAN guideline production, and introduces temporary solutions to unclear points in the guideline production process. State of the art and suggestions for the next two years I. State… Continue Reading
- 
	 Discussions during last year’s Spring Meeting and General Assembly showed that BioMed Alliance Members are affected by Plan S. Due to COVID-19, adaptation to the open access initiative within the foreseen timeline has become even more challenging for medical societies.… Continue Reading Discussions during last year’s Spring Meeting and General Assembly showed that BioMed Alliance Members are affected by Plan S. Due to COVID-19, adaptation to the open access initiative within the foreseen timeline has become even more challenging for medical societies.… Continue Reading
- 
	EMA has published its Regulatory Science Strategy to 2025 today. The strategy provides a plan for advancing regulatory science over the next five years, covering both human and veterinary medicines. It comes in response to the dramatic acceleration of the… Continue Reading
- 
	Executive PageEAN NewsCOVID-19Top ArticlesFeatured SliderEXECUTIVE PAGE: EAN takes swift action against COVID-19 with dedicated initiativeMay 1, 2020Despite some positive slowing of new cases and deaths in some countries, the COVID-19 pandemic has infected until today over 3.5 million people, leading to more than 250,000 deaths across the globe. Without a doubt, the crisis sparked by this pandemic has also wreaked havoc on healthcare systems and economies while causing massive disruption to the everyday lives of people around the world.
- 
	The BMA informs that the application form for the European Commission’s COVID-19 Clinical Management Support System is available here. The European Commission’s COVID-19Clinical Management Support System is based on experiences with the European Reference Networks. It aims to help create… Continue Reading
- 
	News from EAN member societiesCOVID-19Alzheimer Europe rings the alarm about discriminatory practices in intensive care settings during the COVID-19 pandemicMay 1, 2020At an online meeting organised by Alzheimer Europe, representatives from 22 national Alzheimer’s associations from 19 European countries adopted a call to governments and national health systems to urgently increase the infrastructure for intensive care needed for people affected by… Continue Reading
- 
	Prof. B. Bodini interviews Mrs. Joke Jaarsma, President of EFNA – European Federation of Neurological Associations










 
				 
				 
				 
				 
				 
				 
				 
				